Risk factors for recurrent VIN. Role of multifocality and grade of disease
- PMID: 9109080
Risk factors for recurrent VIN. Role of multifocality and grade of disease
Abstract
Objective: To evaluate possible risk factors for recurrence of vulvar intraepithelial neoplasia (VIN): menopausal status, smoking, method of treatment (local excision with cold knife, CO2 laser vaporization, CO2 laser excision), grade and focality.
Study design: At the dysplasia clinic of the Department of Obstetrics and Gynecology, Medical Center, Heinrich Heine University, Dusseldorf, Germany, we treated 102 patients with VIN with a mean follow-up of 3.5 years. VIN was demonstrated for all these patients by histologic examination of biopsies taken under colposcopic control. Follow-up was performed by clinical examination and colposcopy. Statistical evaluation was done by the chi 2 test.
Results: VIN recurrence developed in 36.6% of patients. We could not prove any correlation between recurrence of disease and menopausal status, smoking behavior or treatment method used. Recurrent VIN correlated with the grade (P < .001) and focality (P < .05) of the disease.
Conclusion: In the prediction of possible risk of recurrence of disease, not only the grade of VIN but also the multifocality is important. Treatment should be done very carefully considering the functions of the vulva; therefore, mutilating operations ought to be avoided as much as possible.
Similar articles
-
CO2 laser surgery for vulvar intraepithelial neoplasia. Excisional, destructive and combined techniques.J Reprod Med. 2002 Nov;47(11):913-8. J Reprod Med. 2002. PMID: 12497680
-
Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy.Gynecol Oncol. 2006 Feb;100(2):271-5. doi: 10.1016/j.ygyno.2005.08.012. Epub 2005 Sep 16. Gynecol Oncol. 2006. PMID: 16169064
-
[Risk factors for recurrence of vulvar intraepithelial neoplasia III (VIN III)].Zentralbl Gynakol. 2006 Dec;128(6):347-51. doi: 10.1055/s-2006-942280. Zentralbl Gynakol. 2006. PMID: 17213974 German.
-
Vulvar intraepithelial neoplasia and vulvar cancer.Obstet Gynecol Clin North Am. 1996 Jun;23(2):295-324. Obstet Gynecol Clin North Am. 1996. PMID: 8784883 Review.
-
[Therapy of preinvasive vulvar neoplasia--standardized or individual?].Zentralbl Gynakol. 1996;118(6):345-9. Zentralbl Gynakol. 1996. PMID: 8768011 Review. German.
Cited by
-
Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence.Gynecol Oncol. 2012 Nov;127(2):312-5. doi: 10.1016/j.ygyno.2012.07.118. Epub 2012 Aug 4. Gynecol Oncol. 2012. PMID: 22867736 Free PMC article.
-
CO2 laser colposcopic guided surgery for the see and treat management of VHSIL: a preliminary experience.Lasers Med Sci. 2022 Apr;37(3):1635-1641. doi: 10.1007/s10103-021-03413-y. Epub 2021 Sep 28. Lasers Med Sci. 2022. PMID: 34580789 Free PMC article.
-
Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia.J Gynecol Oncol. 2013 Jul;24(3):236-41. doi: 10.3802/jgo.2013.24.3.236. Epub 2013 Jul 4. J Gynecol Oncol. 2013. PMID: 23875073 Free PMC article.
-
The re-infection rate of high-risk HPV and the recurrence rate of vulvar intraepithelial neoplasia (VIN) usual type after surgical treatment.Med Sci Monit. 2011 Sep;17(9):CR532-5. doi: 10.12659/msm.881941. Med Sci Monit. 2011. PMID: 21873951 Free PMC article.
-
Medical interventions for high grade vulval intraepithelial neoplasia.Cochrane Database Syst Rev. 2011 Apr 13;(4):CD007924. doi: 10.1002/14651858.CD007924.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2015 Aug 18;(8):CD007924. doi: 10.1002/14651858.CD007924.pub3. PMID: 21491403 Free PMC article. Updated.
MeSH terms
LinkOut - more resources
Medical